Edward Carr Insider Trading Activity
Edward Carr has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
DNTH is the most-traded position with 5 trades. The largest single transaction was a sale of DNTH for $1.9M on Mar 12, 2026.
Performance Scorecard
Forward stock performance after each transaction by Edward Carr. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -8.7% | 0% | 5 |
| 90 days | — | +7.7% | 100% | 5 |
| 120 days | — | -17.9% | 0% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersDNTH · Dianthus Therapeutics, Inc. /DE/
🔒 Subscribe to see trade entries
Pro members see exactly when Edward Carr bought and sold DNTH.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 12, 2026 | DNTH | Sell | 15,852 | $80.71 | $1.3M | −36.3% | CHIEF ACCOUNTING OFFICER | |
Mar 12, 2026 | DNTH | Sell | 23,465 | $81.75 | $1.9M | −84.3% | CHIEF ACCOUNTING OFFICER | |
Mar 12, 2026 | DNTH | Sell | 3,865 | $82.66 | $319K | −88.5% | CHIEF ACCOUNTING OFFICER | |
Mar 12, 2026 | DNTH | Sell | 200 | $83.38 | $17K | −40.0% | CHIEF ACCOUNTING OFFICER | |
Mar 12, 2026 | DNTH | Sell | 300 | $85.53 | $26K | −100.0% | CHIEF ACCOUNTING OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 5 | $3.6M |
Other insiders at Dianthus Therapeutics, Inc. /DE/
4 other tracked filers at DNTH.